✦ LIBER ✦

Expert Commentary: Gastrointestinally Active Lipid-Lowering Drug Safety

✍ Scribed by Peter P. Toth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety Considerations with Gastrointesti

✍ Terry A. Jacobson; Annemarie Armani; James M. McKenney; John R. Guyton 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Expert Commentary: The Safety of Fibrate

✍ W. Virgil Brown 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Experts call for active surveillance of

✍ Wadman, Meredith 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

P293 DISCOVERY OF A NOVEL AND POTENT CHO

✍ Kanou, M.; Nishiwaki, Y.; Nakano, A.; Yamanaka, Y. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Lipid-Lowering Efficacy and Safety After

✍ Dr. Sean T. Nguyen; Dr. Susan A. Eaton; Dr. Amy M. Bain; Dr. Anita P. Rahman; Dr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Gemfibrozil, a Lipid Lowering Drug, Inhi

✍ Jana, Malabendu; Pahan, Kalipada 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 824 KB